Patient Engagement Synapse
  • Join now
  • Login
COVID-19 hub
  • Home
  • People
  • Organizations
  • Initiatives
  • Events
  • Resources
  • Conditions
  • Trainings
  • Patient Pledge
    • Take the Pledge
    • The Pledge Record
  • Reports
  • Join now
  • Login

Tony Hoos

Head of Medical for Europe at Amgen
  • Overview
  • Organization 1
  • Initiatives 5
  • Event 1
  • Resources 8
  • Commitments 0

Read more

Tony Hoos currently serves as the Chief of Medical for Amgen in Europe, which includes all therapeutic areas as well as all medical departments in Europe. Tony has been passionate about patient involvement in the development and life cycle of medicines for many years. He has worked extensively with stakeholders to involve patients in the benefit-risk assessment of medicines and he is one of the founders of ‘Patient Focused Medicines Development’ (PFMD), which is a multi-stakeholder initiative consisting of patient organizations and industry in the US and Europe. Prior to Amgen, Tony was a Senior Vice President for GSK at the corporate headquarters in London; his responsibilities over time included European Medical Affairs, Head of the Rare Disease Business Unit and senior associate of the Chief Medical Officer. Prior to joining GSK, Tony was a member of the Executive Management Board of Merck Serono (Geneva, Switzerland); his area of responsibility was Global Drug Development, including Regulatory Affairs, Pharmacovigilance and Medical Affairs. Overall Tony has 25 years of experience in pharmaceutical industry in various global management and medicines development roles for companies in the United States and Europe, including a long career with Aventis and its predecessor companies. Dr. Hoos is a licensed physician; he studied and trained in Germany and the US. He also holds a Masters of Business Administration from the University of Toronto, Canada.

Organizations

Read more

PFMD , Executive Committee

The Patient Focused Medicines Development (PFMD) group, established in 2015, is an independent multinational coalition, managed in collaboration with The Synergist. Its goal is to bring together initiatives and best practices that integrate the voice of the patient throughout the lifecycle of medicines development, thereby speeding up the creation and implementation of an effective, globally standardized framework. PFMD seeks to have a balanced representation of stakeholders to ensure transparency, inclusiveness, and credibility. Stakeholders include patients and patient organizations across diverse areas of health and industry. We also intend to invite regulators, payers and other professional organizations to the global group to ensure diversity of perspectives.

Badges

Social media

Linkedin

see all

Initiatives (5)

  IMI PARADIGM

Innovative Medicines Initiative IMI, The Synergist ,
+ 44

Europe

Completed less than one year ago

  Synapse Patient Engagement Global Landscape, Expert Network and Repository

PFMD, Merck Sharp & Dohme (MSD), EURORDIS - Rare Diseases Europe ,
+ 25

Global

Currently underway

  PFMD - Patient Focused Medicines Development

The Synergist, PFMD, National Health Council ,
+ 23

Global

Currently underway

  Co-creation of the Patient Engagement "Meta-Framework"

PFMD, NIHR INVOLVE, Drug Information Association (DIA) ,
+ 24

Global

Completed over one year ago

  Pledge to Patients

PFMD, The Synergist, National Health Council ,
+ 17

Global

Currently underway

Events (1)

15

Nov09:00 AM

15

Nov05:00 PM

PFMD Board Meeting

+ 3
Belgium
see all

Resources (8)

+ 6

Culture and Process Change as a Priority for Patient Engagement in Medicines Development - Article

12 Jan 2018

+ 6

Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action - Article

12 Jan 2018

+ 1

Patient Focused Medicine Development in a nutshell - Video

12 Jan 2018 Article and blog post

From deciding FOR patients, to deciding WITH patients - Video

12 Jan 2018

Health coalition pursues a unique and global approach to patient engagement - Video

12 Jan 2018

Patient engagement coalition emphasises need for global leaders to work together - Video

12 Jan 2018

+ 5

What do stakeholders expect from patient engagement: Are these expectations being met? - Report

03 Sep 2018

Value of the Patient Engagement Training for Industry and Patients - Tony Hoos (PFMD)

23 Sep 2020 Video

Do you need help?

  • Contact us
  • Help Center
  • Latest updates
  • Cookie privacy options

Useful links

  • About us
  • Features
  • Search tool
  • Terms and Conditions
  • Privacy Policy
  • Geographical
  • Medical scope
  • Timeline
  • Patient matrix
  • Medicine lifecycle

Join our newsletter

Get the latest information on Patient Focused Medicines Development and stay connected with our activities.

5.3.0@prod
© Copyright SYNAPSE 2021. All Rights Reserved Powered by The Synergist.